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GRANULOCYTE/MACROPHAGE COLONY-STIMULATING
FACTOR IS ESSENTIAL FOR THE VIABILITY AND
FUNCTION OF CULTURED MURINE EPIDERMAL
LANGERHANS CELLS
Langerhans cells (LC)' are leukocytes that are distributed in the suprabasal
region of squamous epithelia, particularly skin. LC undergo marked changes
when epidermal cell suspensions are prepared by a standard trypsinization
protocol and placed in culture for 1-3 d. Several cell surface markers (Fc
receptors, the F4/80 antigen, membrane ATPase, and nonspecific esterase)
decrease substantially (1, 2), while others (class I and II products of the MHC)
increase (3). When accessory function for primary T-dependent immune re-
sponses is quantitated, the activity of the LC population increases some 10-30-
fold (1, 4). Therefore LC seem to mature immunologically in bulk epidermal
culture and acquire most of the features of lymphoid dendritic cells.
Because LC maturation leads to the development of accessory function for
primary immune responses, this process may contribute to the sensitization phase
of cell-mediated immunity. Here, we asked whether maturation is autonomous,
or ifexogenous cells and factors are required. We developed a panning technique
to enrich the trace LC population from freshly dissociated mouse epidermis.
When this was done, the viability and function of cultured LC was dependent
upon factors that were found in the medium of keratinocyte cultures, as well as
stimulated macrophages and Tcells. We will describe these experimentsand the
identification ofgranulocyte/macrophage colony-stimulating factor (GM-CSF)as
the principal if not exclusive mediator for the production of functioning LC.
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Epidermal cellswere isolated from mouse ears exactly as described (1) except that 0.5%
trypsin was used. Briefly, dorsal and ventral halves of ear skin were floated on a trypsin
solution for 20 and 40 min, respectively, the epidermal sheets were peeled from the
underlying dermis, and the sheets were dissociated by gentle shaking on a sieve. Ia+ LC
accounted for ^-1% of the cell suspensionand were enriched by the following procedure.
Most Thy-l' keratinocytes (6) were removed by treating the suspension for 1 h in
cytotoxicity medium (RPMI-1640 supplemented with 1% BSA and 25 mM Hepes buffer)
at 3 x 106 cells/ml with mAb anti-Thy-1 (culture supernatant from clone 13.4, TIB 99
from the American Type Culture Collection [ATCC], Bethesda, MD) and complement
(3-4-wk-old rabbit serum from Pel-Freeze, Rodgers, WI). 80-90% of the suspended cells
became trypan blue-positive. To remove dead cells, the suspension was diluted in HBSS,
centrifuged, and resuspended in 0.1 % trypsin with 80 Kg/ml DNase in HBSS at 106 viable
cells per milliliter. After 20 min at 37°C, the cellswere diluted in RPMI-1640 with 10%
FCS, centrifuged, and resuspended to 106 cells/ml in an mAb that would selectively bind
to the LC (-7-15% of the suspension at this point). For most experiments, the mAb was
rat anti-mouse leukocyte common antigen (7) (clone M 9/1, TIB 122 from ATCC). In
our initial work, the mAb were to MHC class II products (8, 9) (clones B21-2, rat anti-
mouse I-Anal, TIB 229; and clone 14-4-5S, mouse anti-mouse I-A"', HB32 [ATCC]).
mAbs were added as hybridoma culture supernatant at 30% vol/vol to cellsat 106 cells/ml
for 30 min at 4°C in RPMI-1640 culture medium supplemented with 10% FCS. The
suspension was washed twice in this medium and applied to bacteriologic Petri dishes (35
or 60 mm; Falcon 1007 or 1008; Falcon Labware, Oxnard, CA) that had been coated for
1 h with a goat anti-mouse Ig in PBS (0211-0121, 32 ug per 60-mm dish; Cappel
Laboratories, Cochranville, PA) or goat anti-rat Ig (01-16-12, 12 ug per 60-mm dish;
Kirkegaard and Perry Laboratories, Gaithersburg, MD). The cells settled for 30 min at
4°C, and then 10 min at room temperature. Nonattached cells were removed with a
Pasteur pipette after swirls of the dish and monitoring for loose cells under an inverted
microscope. The attached, LC-enriched cells were then eluted by competition with either
rat or mouse Ig (500 gg/ml PBS;Jackson ImmunoResearch) for 45 min at 4°C, and then
pipetted into 1 .5-ml conical polypropylene tubes. After centrifugation, the cells were
resuspended to 3-5 x 105 cells/ml for further culture or analysis. The yields were 1-2 x
106 epidermal cells per ear and 1-3 x 10' LC/mouse. >90% of the la' cells that were
applied to the anti-Ig plates were recovered in the adherent fraction. The same panning
procedure was also used on epidermal suspensions that had been cultured 1-3 d as
described (1) . Before panning, the cultured suspension was treated with 0.1% trypsin to
remove dead cells, and then panned with antileukocyte or anti-la mAb as above.
Frequency ofLC
LC enrichment and yields were determined by immunofluorescent staining with anti-
la antibodies. We used FITC-1121-2 (anti-I-Anal at 1-3 ;ig/ml), or biotin 14-4-5S (anti-1-
Ed,' at 3-6 wg/ml) followed by phycoerythrin avidin (Becton-Dickinson Immunocytometry
Systems, Mountain View, CA). Negative controls were LC from the inappropriate haplo-
type and FITC-anti-Thy-1 (a rat IgG2b, isotype-matched with B21-2 and purchased from
Becton-Dickinson Immunocytometry Systems). The immunofluorescent staining was per-
formed on cellsthat were cytospun (Shandon Southern Instruments, Inc., Selwickley, PA)
onto glass slides, or attached to poly-L-lysine-coated multiwell dishes. Alternatively, the
suspensions were monitored by cytofluorography using a FACS 440 as described (3).
Culture ofEnriched LC
LC were enriched by panning to -80% purity (see Results) and resuspended in culture
medium that consisted of RPMI-1640 supplemented with 10% FCS, 5 x 10-5 M 2-ME,
20 ug/ml gentamicin, 100 U/ml penicillin, and 25 kg/ml streptomycin. A variety of
conditioned media and defined cytokines (see below) were added to look for effects on
LC viability and function. 3.0-5.0 x 10' enriched LC in 0.2 ml were plated in 6-mm flat-
bottom microtest plates (3596; Costar, Cambridge, MA). After overnight culture, most1486
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of the contaminating keratinocytes had adhered to the dishes. The nonadherent popula-
tion with >95% LC was removed by pipetting and cultured an additional 0-3 d. Before
testing accessory function, these cultured LC were washed free of most of the culture
medium by centrifuging the cells in the microculture plates. We spun the plates twice,
each time at 1,000 rpm for 2 min in a Sorvall RT6000 centrifuge followed by resuspension
in fresh medium. The cells were finally resuspended to 0.2 ml for viable cell counts and
for use as accessory cells in stimulating the primary mixed leukocyte reaction (MLR).
ConditionedMedia
Keratinocyte-conditioned Medium (KCM).
￿
Epidermal cell suspensions were plated in 100-
mm plastic dishes (3003; Falcon Labware) at 15-20 X 106 cells/plate in culture medium
(see above). After overnight culture, few if any LC but most of the keratinocytes had
adhered forming a dense but subconfluent monolayer (1). Nonadherent cells were
removed by pipetting over the monolayer. The adherent cells were cultured for 2-3 d to
provide KCM. Three different batches of KCM were prepared in this way and found to
be active in supporting the maturation of enriched LC in culture (see Results). The
medium was centrifuged at 280 g, filtered through 0-45-jum Millipore filters, aliquoted,
and stored frozen at -20'C.
Macrophage-conditioned Medium.
￿
24-h-conditioned media were prepared from theJ774
and RAW mouse macrophage cell lines, thioglycollate-elicited peritoneal macrophages,
and from Fc receptor-positive (macrophage-enriched) fractions of spleen adherent cells
(10, 11). The cells were cultured at 5-10 X 105 cells/ml for 24 h with or without
stimulation with 10 ug/ml LPS (Salmonella typhosa; Difco Laboratories, Detroit, MI), 1
U/ml murine rIFN-f (Genentech Inc., South San Francisco, CA), or 50-100 U/ml murine
rIL-la (Hoffman-LaRoche, Inc., Nutley, NJ).
NaturalSources ofCSFs.
￿
The WEHI and L cell lines were used to provide conditioned
media with mouse IL-3 (12) and M-CSF respectively (13). Both media actively supported
the development of macrophages in liquid cultures of 0.5 X 106 mouse bone marrow cells
in 16-mm plastic wells in DMEM with 10% FCS and antibiotics. Purified natural mouse
M-CSF (13) was kindly provided by Dr. R. Stanley (Albert Einstein Medical College,
Bronx, NY).
MLR-conditioned Medium.
￿
Primary MLRs were generated between 3 X 104 dendritic
cells and 3 X 106 allogeneic T lymphocytes in 1-ml macrocultures (14). The conditioned
medium was collected at 3 d.
Purified Cytokines
We were generously provided with a large panel of recombinant cytokines (13, 15-19)
by several colleagues (Table 1). The cytokines with CSF activity (IL-3, GM-CSF, G-CSF,
M-CSF) were tested on mouse marrow cultures (see above) to ensure their efficacy.
Anticytokine Antibodies
Three high-titer polyclonal antisera were tested for neutralization of keratinocyte
conditioned media. Rabbit anti-mouse GM-CSF serum (16) was kindly provided by Dr.
S. Gillis, Immunex Corp. A 1 % vol/vol dose fully neutralized 10 ng/ml rGM-CSF. Ig
fractions of rabbit anti-mouse rTNF and sheep anti-mouse natural IFN-a/# were giftsof
Dr. E. A. Havel], Trudeau Institute and were used at a dose of 1-5 X 10' neutralizing
U/ml. The antibodies were mixed with conditioned media for 1 h before addition to the
LC cultures.
Accessory Function
Accessory function was tested in the primary MLR. It was shown previously that the
capacity of primary populations of leukocytes to act as MLR stimulators required some
accessory function m addition to the expression ofMHC-encoded transplantation antigens.
For example, Ia' lymphoid dendritic cells and cultured epidermal LC were powerful
MLR stimulators (1, 4), while freshly isolated LC and IFN-.y-stimulated macrophages were
weak in spite of the expression of large amounts of class 11 MHC products (1, 4, 8, 14).WITMER-PACK ET AL.
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Therefore stimulatory activity in the primary MLR was used as a measure ofthe accessory
function that is required for the activation of antigen-specific, resting T cells. We added
graded doses of LC, or splenic dendritic cells (10) to a fixed dose of 3 x 105 allogeneic,
la-, nylon wool-nonadherent, spleen or lymph node T cells in 0.2-ml culture medium in
flat microtest wells. The LC were used with or without treatment with 900-1,500 rad of
ionizing "'Cs irradiation, with similar results. On day 4 or 5 of the MLR, 1 J,Ci [5H]TdR
was added, and ['H]TdR uptake was measured 8 h later. Standard deviations of triplicate
cultures were <10%, and were not shown.
Results
EnrichmentofLC by Panning.
￿
la' LC compose -1 % of ear epidermal suspen-
sions (1), so that an enrichment method had to be developed to study the
properties of LC in the absence of keratinocytes. A panning technique provided
LC in sufficient purity. The bulk of the epidermal keratinocytes were killed with
anti-Thy-I and complement, and then the LC were positively selected by expo-
sure to specific mAb and panning on anti-Ig-coated plates. In the first experi-
ments we used anti-la, and in subsequent experiments, anti-leukocyte common
antigen. Neither mAb bound significantly to keratinocytes (20).
By phase-contrast and immunofluorescence microscopy (Fig. 1, A and B), it
was evident that panning enriched the LC from a starting incidence of -I% to
a level of 80-85%. A small subpopulation of LC stained more brightly with anti-
la (arrows, Fig. 1, B and C). Quantitation by flow cytometry revealed that the
mean level of LC la approached that of the la-rich dendritic cells from spleen
(Fig. 1 C). Staining with the mAb FITC-1121-2, which specifically stains I-Ad and
not I-Ak LC (Fig. 1 C), was used to monitor LC content in subsequent experi-
ments.
To test the effect of the LC enrichment procedure on accessory function, the
MLR-stimulating activity of splenic dendritic cells and cultured LC was evaluated
with or without treatment with anti-Thy-1 and complement followed by panning.
In eight experiments, panning shifted the dose-response curve of MLR-stimulat-
ing function by a factor of two at most, and sometimes not at all (Fig. 2, A and
B, respectively).
When fresh LC were tested as MLR stimulators and compared with splenic
dendritic cells (Fig. 2C) or to cultured LC (Fig. 2D), the day 0 LC were 10-20
times less active, which is in accordance with previous results in which LC were
enriched by another method (4) . We conclude that LC can be significantly
enriched by panning, and that the use of this method allows one to observe the
marked increase in accessory function that occurs during bulk epidermal culture.
LC Viability and Function Is Mediated by KCM.
￿
LC were isolated from fresh
epidermal suspensions and cultured with or without supplementation with KCM .
During the first day of culture, many of the contaminating keratinocytes adhered
to the surface of the culture dish, and then the nonadherent, highly enriched
LC could be transferred to fresh wells. LC morphology, expression of la, and
viability (Fig. 3A) were not measurably changed by the addition of KCM during
the first day of culture. The expression of la increased fivefold with or without
KCM (not shown), as noted before in bulk epidermal cultures (3). However, the
addition of KCM was critical for viability on the second and third days of culture .
In the absence of KCM, viable cell yields fell markedly, while with KCM, viable1488
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FIGURE 1 . Features of LC after enrichment by panning . A. Phase-contrast microscopy
following adherence to poly-L-lysine-coated multiwell slides . Most of the cells have the
appearance of leukocytes. The small numbersof keratinocytes (black arrows) are larger, have
asmooth surface, and often contain cytoplasmic granules. x 300 . B. Immunofluorescence with
anti-Ia . Same field as A, but stained with FITC-1321-2, anti-I-A b .d . Note that some of the LC
(white arrows) stain more brightly . This fraction typically is <5% of the total Ia' cells. C.
Cytofluorography . LC were panned from (C x D2)F, (I-Ad) andA (I-A'°) mice with antileu-
kocyte mAb and compared with (C x D2)F, spleen dendritic cells (DC) (---) . The staining
reagents were FITC-1321-2, anti-I-A
b,d (thick line) or the isotype-matched, IgG2b FITC-Thy-
1 .2 as control (dotted line). Thy-1 is expressedon contaminating keratinocytes butnot LC (20).
Note that FITC-1321-2 stains I-Ad but not I-A' LC, and that the mean level of staining is
comparable to splenicDC . The small subset of Ia-rich LC is evident (arrow) .E
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MLR-stimulating
activity of panned LC and dendritic cells
.
Graded doses of LC
or
dendritic cells were added to 3 X 105 allogeneic, nylon-nonadherent, la-, spleen cells
.
The
MLR
was monitored on day 4 by measuring ['H]TdR uptake
.
A
.
Panning has little effect on
the
function of splenic dendritic cells
.
Low-density spleen adherent cells (10), from (B6 X
D2)F,
mice, were cultured overnight and rosetted with antibody-coated red cells to deplete
macrophages.
One portion of the enriched dendritic cells was panned with anti-la (O), and the
other
was not (0)
.
The dendritic cells were then used as stimulators for the MLR of B6
.H-2k
T
cells
.
B
.
Panning does not affect the accessory function of cultured LC
.
Epidermal cell
suspensions
were cultured 3 d
.
A low-density, LC-enriched fraction was isolated (50% Ia' LC)
as
described (1)
.
One part of the cells was tested as MLR stimulators without further treatment
(O),
while the other part was enriched with anti-Thy-1 plus complement, followed by panning
(A).
C
.
Comparison of freshly isolated LC and splenic DC as MLR stimulators
.
LC were
enriched
by panning (p)
.
Splenic DC (O) were low-density spleen adherent cells that were
dislodged
from the culture surface after5 h of culture
.
D
.
Comparison of freshly isolated and
3-d-cultured
LC as MLR stimulators
.
LC were enriched by panning from fresh (open symbols)
or
3-d-cultured (closed symbols) epidermal suspensions
.
In one experiment (circles), the stimu-
lators
were strain A and the responders strain (C X D2)F,
.
In the other (triangles), the
stimulators
were (B6 X D2)F, and responders (C X D2)F,
.
cell
yields fell by a small extent (Fig
.
3 A)
.
No mitotic figures were observed, but
the
morphology of the KCM-supplemented LC changed significantly
.
The LC
enlarged
and developed numerous dendritic and veiled processes (Fig
.
3, B and
C) .
The level of Ia on 1- and 3-d-cultured LC did not change (not shown)
.
In
the presence of KCM, the MLR-stimulating activity of cultured LC rose
>10-fold
relative to that observed at time 0 (Fig
.
4)
.
The accessory function of
purified
LC cultured with KCM was similar to that seen with LC isolated from
bulk
3-d epidermal cultures (Fig
.
4)
.
Three different KCM preparations were
tested
with similar results
.
A plateau in LC-stimulating activity was observed1490
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FIGURE 3.
￿
Effect of KCM on LC viability and morphology . LC were enriched to ^-80%
purity by panning with anti-la mAb . The LC were then cultured with or without30% (vol/vol)
KCM. Most contaminating keratinocytes (20% of the starting inoculum, Fig . 1) adhered to
the culture surface during the first day of culture. A . Viable cell recoveries as assessed by
trypan blue staining . Data are means from three experiments. B and C. Cytologic features of
1- (B) and 3-d (C) enriched LC, cultured in the presence of 30% (vol/vol) KCM. Both
populations are uniform in appearance, but the cells in 3-d cultures are larger and have longer
processes. X 500 .
after culture in a dose of 10-30% vol/vol KCM. We conclude that the viability
and function of cultured LC is markedly enhanced inKCM.
Effects of Other Conditioned Media on LC Viability and Function.
￿
The condi-
tioned medium from LPS-stimulated macrophages was, like KCM, active in
supporting the viability and function of cultured LC (Fig . 5A) . Active medium
was obtained from all LPS-treated macrophage populations that we tested,
including theJ774 and RAW cell lines, thioglycollate-elicited peritoneal macro-
phages, and Fc receptor-positive splenic adherent cells . LPS had no direct effect
on cultured LC . Even when mixed with the medium from unstimulated macro-
phages, LPS did not enhance LC viability or function (not shown). rIFN-y and
r1L-1a were weak or inactive in stimulating the release of the required cytokinesFIGURE 5.
￿
Change in LC accessory
function after culture with KCM and
other conditioned media. A. Macro-
phage-conditioned media: LC were
panned from freshepidermal suspen-
sions and cultured for 3 d in the
presence of 30% (vol/vol) macro-
phage-conditioned medium obtained
as follows. 5 X 106 adherent, thio-
glycollate-elicited peritoneal macro-
phages were cultured 24 h in 5 ml
culture medium and 10 jug/ml LPS
(A), 1 U/ml murine rIFN-y (A), 50
101
￿
t03 ￿10 ° ￿10 2 ￿10 3
￿
U/ml murine IL-1 (A), or no supple-
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￿
ment(A).Additionally, 106 Fcrecep-
tor-positive (isolated by rosetting
with antibody-coated red cells)
splenic adherent cells(10) were cultured 24 h with (/) or without(p) 10 ug/ml LPSin 1 ml medium.
Companion LC preparations were cultured with (0) or without (Q) KCM. Each preparation was
washed andtested forMLR-stimulatory function. B. WEHI and Lcell conditioned medium: LC were
panned from fresh epidermal suspensions with antileukocyte mAb and cultured 2 d with 75%
(vol/vol) keratinocyte-("), Lcell- (El), or WEHI- (A)conditioned media. The cells were washed and
tested as MLR stimulators.
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FIGURE 4. Change in LC accessory function after
culture with KCM. LC were enriched from fresh
epidermal suspensions by panning with anti-Ia mAb
and then cultured 3 d with (40) or without ((D) 75%
(vol/vol) KCM. The cells were washed free of KCM
andbrought to aconstantvolume. Thetopstimulating
dose is a reflection of relative cell yields with or
without KCM. Freshly panned day 0 LC (C!) were
included as a comparison, as were LC isolated by
panning from bulk 3-d epidermalsuspension cultures
(A) a part of which had been used 3 d earlier to
prepare the LC that were cultured with or without
KCM. In this and all subsequent experiments, stimu-
lators were from (C X D2)F, mice and responders (3
X 105, la-, nylon nonadherent T cells) were from
strain A. ['H]TdR uptake was measured at 72-88 h.
from macrophages (Fig. 5A). In contrast to mouse macrophages, LPS-stimulated
human monocytes did not produce a factor that could act on mouse LC (not
shown).
The conditioned medium from the syngeneic and allogeneic MLR also medi-
ated the maturation of LC in culture (data not shown). However, the medium
from the WEHI cell line and from L cells, which are used as standard sources of
IL-3 and M-CSF, were repeatedly inactive in inducing LC maturation (Fig. 5B).
These media did stimulate the expected development of macrophages in marrow
cultures (not shown).
GM-CSF Is the Factor that Mediates the Maturation of LC in Culture.
￿
A panel
ofpurified cytokines (Table I) was then added to LC cultures. Most were inactive
(not shown) including: IL-1 (15), IL-2, IL-3 (19), IL-4 (18); G-CSF (17), and M-
CSF (13); cachectin/TNF, IFN-a/0/7.
However, when rGM-CSF (Fig. 6) and purified natural GM-CSF (not shown)
were evaluated, the LC behaved identically to cultures supplemented with KCM
or with macrophage-conditioned medium. In the presence of low doses of GM-1492
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TABLE I
Cytokines Tested on EpidermalLangerhans Cells
* U/mg except wherestated.
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FIGURE 7. Anti-GM-CSF reduces the ac-
tivity ofKCM. LC wereenriched from fresh
epidermal suspensions by panning with an-
tileukocyte mAb and cultured 3 d with
KCMand the indicatedsupplements before
washingand testingas MLRstimulators. A.
LCwere cultured with: 75% (vol/vol) KCM
(0), KCMplus 1%rabbit preimmuneserum
(0), KCM plus rabbit anti-GM-CSF (A), or
with KCM plus anti-GM-CSF plus 100
ng/ml rGM-CSF (A). B. LC were cultured
with 30% (vol/vol) KCM (40), with KCMand
1% rabbit anti-GM-CSF (A), KCM and rab-
bitanti-mouse TNF(O)or KCMand sheep
anti-mouse IFN (O).
Cytokine Expressed
in Activity Dose Source
MouserIL-Ia E. coli 6 x 106 10-20 ng/ml P. LoMedico, Hoffman-La-
Roche, Nutley, NJ
Mouse rlFN--t E. coli 6 x 106 2-20 ng/ml Genentech, South San Francisco,
CA
Mouse rIL-3 COs - 3-10% vol/vol T. Yokota, DNAX, Palo Alto,
CA
Mouse rIL-4 COs - 200-1,000 U/ml T. Mosmann, DNAX
Mouse M-CSF Natural 8 x 107 100-3,000 U/ml R. Stanley, Albert Einstein Col-
lege of Medicine, Bronx, NY
MouseIFN-a/# Natural 105 U/ml 100-1,000 U/ml E. Havell, Trudeau Institute,
Saranac Lake, NY
Mouse rGM-CSF Yeast >4 x 107 0.01-100 ng/ml S. Gillis, Immunex, Seattle, WA
MouseGM-CSF Natural - 10-100 U/ml Genzyme, Boston, MA
Human rIL-2 E. coli 5.3 x 106 2-20 U/ml S. Rudnick, Biogen, Cambridge,
MA
Human rTNF Yeast 108 10 U/ml B. Beutler, A. Cerami, S. Wolpe,
(cachectin) The Rockefeller University,
NewYork
Human rG-CSF E. coli 8 x 107 60 U/ml M. Moore, Sloan Kettering, New
York1494
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CSF, the LC remained viable, developed many processes, stained brightly with
anti-la mAb, and become very active MLR stimulators (Fig. 6, A-C). Half-
maximal activity was observed at ^-5 pM (0.1 ng/ml; Fig. 6C).
Three polyclonal antisera were then evaluated to test if the function of KCM
could be inhibited. Rabbit anti-GM-CSF blocked the effect of KCM, and the
block was reversed by adding back an excess (100 ng/ml) ofrGM-CSF (Fig. 7A).
Rabbit anti-TNF and sheep anti-IFN-a//3 did not block the effect of KCM (Fig.
7B). Taken together, the results indicate that GM-CSF is the principal if not
exclusive mediator of LC maturation in culture.
Effects of GM-CSF on the MLR.
￿
To ensure that the observed effects of GM-
CSF were on the maturation of LC before addition to the MLR, we added GM-
CSF to MLRs that were induced by graded doses of cultured LC (Fig. 8) or
splenic dendritic cells (not shown). Anti-GM-CSF did not block the MLR-
stimulating activity of LC that had matured in the presence of cytokine (Fig.
8A). Exogenous GM-CSF did not enhance the MLR, but it did induce myeloid
colonies and some background proliferation in the unstimulated T cells (Fig.
8B). We conclude that GM-CSF mediates the immunologic maturation ofLC in
culture, but it does not influence subsequent dendritic or T cell function in the
MLR.
Discussion
LC Enrichment by Panning.
￿
To study the mechanism whereby epidermal LC
become active accessory cells during culture (1, 2, 4), it was necessary to separate
this trace cell type from most of the keratinocytes in the starting epidermal
suspension . We considered several enrichment methods at the outset. We were
unable to remove all keratinocytes by cytotoxicity approaches (anti-Thy-1 or an-
tidesmosomal antibodies and complement). Cytotoxicity was useful as a first step,
however, and provided a preliminary enrichment from an initial level of ^-1
LC to a level of 7-15% LC. Cell sorting of these partially enriched populations
on the FACS could provide LC in >95% purity (4), but we encountered
substantial losses in yield and viability during the sorting procedure. Therefore
we coated the epidermal suspensions with either antileukocyte or anti-la mAb,
washed, and panned on dishes coated with anti-Ig. Panning depleted >90% of
the LC from the applied suspension and did not markedly reduce the accessory
function of the attached cells (Fig. 2). The panned LC were sufficiently pure to
establish a dependence on exogenous cytokines for viability and function (Figs.
3-8).
The Effects of Keratinocyte-conditioned Medium and GM-CSF on Cultured
LC. The addition ofappropriate cytokines to enriched populations offresh LC
had three effects over a 2-3-d period of culture: cell viability was maintained at
^"50% of the starting inoculum; the LC became larger and exhibited many
processes and veils; and stimulating capacity in the primary MLR increased 10-
20-fold. As a result of the combined effects on viability and function, the
stimulating activity of 3-d cultured LC populations was typically enhanced 100-
fold by exogenous cytokines.
The actual increase in the stimulating activity of individual LC might have
been even greater than is suggested by our data (Fig. 4). This is because some ofWITMER-PACK ET AL.
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the activity that was seen with fresh populations could be due to a fraction of la-
rich LC (Fig. 3, B and C) that either were in the process of maturing in situ or
had been exposed to small amounts of GM-CSF during the preparation of the
epidermal suspension. It is possible that the majority of LC in the starting
population have insignificant accessory function.
The increased accessory activity that was induced by KCM or GM-CSF might
be due to three effects. One relates to improved viability (Fig. 3), which is a
characteristic effect of CSFs on their target cells (21, 22). We suspect that
enhanced viability is not the only effect of GM-CSF since, in isolated instances
(perhaps related to higher levels of contaminating keratinocytes), LC viability
was maintained close to the level of that seen with GM-CSF, but little or no
increase in accessory function was observed. A second factor is the increase in
the level of la or class II products that occurs in culture (3). Freshly isolated LC
have similar amounts of la to splenic dendritic cells (Fig. 1), but are much less
active as MLR stimulators (Fig. 2C). We have also found that la levels increase
in cells that are cultured in the absence of KCM for a day, yet there is little
increase in accessory function (M. Witmer-Pack, unpublished observations).
Therefore the levels of la on LC do not seem to be the sole determinant ofthe
level of accessory function. We propose that GM-CSF exerts a third differentia-
tion effect that allows the LC to become an active accessory cell comparable to
the dendritic cells isolated from lymphoid organs and lymph. This differentiation
results in an accessory cell that can cluster and activate resting, antigen-specific
T cells in a manner analogous to that seen with lymphoid dendritic cells (4).
Implications of Our Data in Pinpointing the Lineage of Langerhans Cells.
￿
Both
LC and lymphoid dendritic cells are bone marrow derived (23, 24), but their
precise lineage is not established. It is ofinterest that GM-CSF mediates differ-
entiation of both major types of myeloid cells, granulocytes and macrophages,
whereas G- and M-CSF are more lineage specific (21, 22). Because LC are
influenced by GM-CSF but not by G- or M-CSF, we suggest that LC represent a
type of myeloid lineage that is distinct from typical phagocytes. This would be
consistent with prior data demonstrating stable differences in phenotype and
function between dendritic cells and mononuclear phagocytes (25).
Comparison of the Effects of GM-CSF on LC with the Effects of Other Cytokines on
Accessory Cells. It is becoming evident that the accessory function of dendritic
cells for primary T cell responses like the MLR can be increased by cytokines.
IL-I amplifies the function of lymphoid dendritic cells about threefold, but the
cells are already very active before exposure to cytokine (26). GM-CSF does not
increase the function of mature LC (Fig. 8) or splenic dendritic cells (data not
shown). It instead acts on freshly isolated LC, which quantitatively are weak
stimulators of the MLR and polyclonal T cell mitogenesis (1, 4). GM-CSF
therefore may be specialized to mobilize active dendritic cells from a weakly
active, nonlymphoid tissue source.
Two other T cell-derived products enhance the expression of class II MHC
products but do not appear to induce accessory cells for primary responses. IFN-
.y increases the expression of la on mononuclear phagocytes (27) and many
nonleukocytes. The lymphokine-treated macrophages do not act as stimulators
of the primary MLR (8, 26), but are better presenting cells for sensitized CD4+1496￿
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Tlymphocytes (14). IL-4 or BSF-1 is a cytokine thatenhances la on small mouse
B lymphocytes (28). Here too the upregulated B cells are weak in stimulating a
primary MLR but are active in presenting alloantigens to freshly sensitized T
lymphoblasts U. Metlay, M. Birkeland, R. Steinman, and E. Pure; unpublished
results) .
It is noteworthy that both cytokines that modulate the function of dendritic
cells for primary responses can be released in the absence of sensitized T cells.
IL-1 and GM-CSF are produced by such non-T cells as macrophages and
keratinocytes. Therefore these cytokines could be released during the afferent
limb of the immune response, perhaps in nonlymphoid organs where many
antigens are first deposited, where they may be critical for the production of
active dendritic cells. In contrast, IFN-y and IL-4 are the products of T cells
that have alreadybegun to respond to antigen. IFN-yand IL-4 mightbe expected
to enhance T cell-macrophage or T-B cell interactions in the efferent limb of
immunity.
We are extending our studies to test if GM-CSF alters dendritic cell function
in situ. Given the role of GM-CSF as a mediator of dendritic cell maturation in
culture, we are interested in testing if this cytokine can mobilize dendritic cells
from tissues and/or act as an adjuvant during primary immune responses.
Summary
A panning method has been developed to enrich Langerhans cells (LC) from
murine epidermis. In standard culture media, the enriched populations progres-
sively lose viability over a 3-d interval. When the cultures are supplemented with
keratinocyte-conditioned medium, LC viability is improved and the cells increase
in size and number of dendritic processes. Accessory function, as monitored by
stimulating activity in the mixed lymphocyte reaction (MLR), increases at least
10-20-fold. The conditioned media ofstimulated macrophages and T cells also
supportthe viability and maturation ofcultured LC. A panel ofpurified cytokines
has been tested, and only granulocyte/macrophage colony-stimulating factor
(GM-CSF) substitutes for bulk-conditioned medium. The recombinant molecule
exhibits half-maximal activity at 5 pM. Without activity are: IL-1-4; IFN-a/,Q/'y;
cachectin/TNF; M- and G-CSF. A rabbit anti-GM-CSF specifically neutralizes
the capacity of keratinocyte-conditioned medium to generate active LC. How-
ever, GM-CSF is not required for LC function during the MLR itself.
We conclude that the development ofimmunologically active LC in culture is
mediated by GM-CSF. The observation that these dendritic cells do not respond
to lineage-specific G- and M-CSFs suggests that LC represent a distinct myeloid
differentiation pathway. Because GM-CSF can be made by nonimmune cells and
can mediate the production ofactive dendritic cells, this cytokine provides a T-
independent mechanism for enhancing the sensitization phase of cell-mediated
immunity.
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